Skip to main content
. 2023 Apr 10;8(7):e165002. doi: 10.1172/jci.insight.165002

Figure 5. LATS and YAP phosphorylation in ADR-treated KIBRA-OE mice.

Figure 5

Adriamcyin-treated KIBRA-OE mice show (A) a nonsignificant increase in p-LATS/LATS expression compared with control mice (n = 9 control, 9 KIBRA-OE mice) and (B) significantly increased p-YAP/YAP expression compared with control mice (n = 8 control, 9 KIBRA-OE mice). Original magnification, ×40. Scale bars: 50 μm. **P < 0.01 by 2-tailed Mann-Whitney test. NS, not significant.